Number of subjects [Power / Sample Size]

posted by olacy – Hungary, 2007-02-02 16:10 (7086 d 19:14 ago) – Posting: # 503
Views: 8,632

Dear All,

How can I argue for the increased number of subjects in case of a highly variable drug? To set the power to 90% (from 80%) or should I refer to the very high CV% (for example 45%, power=80%)?
Which is less risky? I think the latter one.
I think that the power could not be changed subsequently if the biostudy failed because of 90% power but would pass with 80%.
Please confirm and advise.
When is it needed to increase the power to 90%?
Thanks in advance!

Best regards,
olacy

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
279 visitors (0 registered, 279 guests [including 18 identified bots]).
Forum time: 12:25 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5